Is China Shineway Pharmaceutical Group Limited a good investment? China Shineway Pharmaceutical Group Limited (2877.HK) is currently trading at 8.19 HKD.
In terms of valuation, the stock trades at a P/E ratio of 5.51. This relatively low multiple may signal that China Shineway Pharmaceutical Group Limited is undervalued compared to historical market norms.
Earnings Schedule: China Shineway Pharmaceutical Group Limited is expected to release its next earnings report on March 30, 2027. The market consensus estimate for Forward EPS is 1.25.
For income investors, China Shineway Pharmaceutical Group Limited pays a dividend yield of 17.60%. With a payout ratio of 45%, the dividend appears sustainable.
Yes, it pays an annual dividend of 1.21 HKD (17.60% yield).
China Shineway Pharmaceutical Group Limited is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be March 30, 2027. The company currently has a trailing EPS of 1.47.
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.65 HKD
|
| May 17, 2027 (estimated) | 0.6512 |
| ▸2026 |
1.42 HKD
|
| Sept. 25, 2026 | 0.9330 |
| May 19, 2026 | 0.4870 |
| ▸2025 |
0.51 HKD
|
| Sept. 26, 2025 | 0.1200 |
| May 20, 2025 | 0.3850 |
| ▸2024 |
0.58 HKD
|
| Sept. 27, 2024 | 0.1200 |
| May 17, 2024 | 0.4610 |
| ▸2023 |
0.47 HKD
|
| Sept. 29, 2023 | 0.1180 |
| May 17, 2023 | 0.3530 |
| ▸2022 |
0.38 HKD
|
| Sept. 29, 2022 | 0.1250 |
| May 18, 2022 | 0.2580 |
| ▸2021 |
0.72 HKD
|
| Sept. 28, 2021 | 0.4696 |
| June 17, 2021 | 0.2484 |
| ▸2020 |
0.22 HKD
|
| Oct. 29, 2020 | 0.1236 |
| June 18, 2020 | 0.0983 |
| ▸2019 |
0.26 HKD
|
| Oct. 30, 2019 | 0.1208 |
| June 18, 2019 | 0.1399 |
| ▸2018 |
0.39 HKD
|
| Oct. 30, 2018 | 0.1262 |
| June 15, 2018 | 0.2615 |
| ▸2017 |
0.23 HKD
|
| Oct. 30, 2017 | 0.1300 |
| June 16, 2017 | 0.1014 |
| ▸2016 |
0.24 HKD
|
| Oct. 28, 2016 | 0.1280 |
| June 17, 2016 | 0.1076 |
| ▸2015 |
0.28 HKD
|
| Oct. 13, 2015 | 0.1334 |
| June 19, 2015 | 0.1500 |
| ▸2014 |
0.23 HKD
|
| Oct. 31, 2014 | 0.1100 |
| June 19, 2014 | 0.1200 |
| ▸2013 |
0.20 HKD
|
| Oct. 31, 2013 | 0.1100 |
| June 20, 2013 | 0.0900 |
| ▸2012 |
0.31 HKD
|
| Oct. 15, 2012 | 0.1344 |
| June 1, 2012 | 0.1720 |
| ▸2011 |
0.28 HKD
|
| Oct. 31, 2011 | 0.1100 |
| June 8, 2011 | 0.1700 |
| ▸2010 |
0.25 HKD
|
| Oct. 12, 2010 | 0.1278 |
| June 3, 2010 | 0.1200 |
| ▸2009 |
0.22 HKD
|
| Oct. 19, 2009 | 0.1000 |
| May 18, 2009 | 0.1200 |
| ▸2008 |
0.12 HKD
|
| Sept. 24, 2008 | 0.0100 |
| April 30, 2008 | 0.1100 |
| ▸2007 |
0.23 HKD
|
| Sept. 7, 2007 | 0.1278 |
| April 30, 2007 | 0.1000 |
| ▸2006 |
0.14 HKD
|
| Aug. 30, 2006 | 0.1162 |
| April 27, 2006 | 0.0200 |
| ▸2005 |
0.12 HKD
|
| Sept. 1, 2005 | 0.1162 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| China Shineway Pharmaceutical Group Limited | Sep 25, 2026 | Upcoming | 0.933 HKD |
| China Shineway Pharmaceutical Group Limited | May 19, 2026 | Paid | 0.487 HKD |
Community Discussion